Clinical studies have shown that CD4+CD25+ cells are often present within the tumor mass, and have reported a link between a presence of a tumor and an increase in the proportion and/or the number of CD4+CD25+ Tregs in the blood (43–47). This evidence concerns the gene CD4 and neoplasm.